Related Experiment Video
Updated: Apr 18, 2026

10:46
Doppler Optical Coherence Tomography of Retinal Circulation
Published on: September 18, 2012
18.7K
Comparison of Glaucoma Detection Performance of Binocular Perimetry Screening Program Using imo Perimetry With
Euido Nishijima1, Daisuke Hosaka1,2, Shumpei Ogawa1,3
1Department of Ophthalmology, The Jikei University School of Medicine, Nishi-shimbashi, Tokyo, Japan.
Translational Vision Science & Technology
|August 5, 2024
Summary
The head-mounted binocular visual perimeter "imo" screening program (ISP) is a non-inferior and faster method for glaucoma detection compared to frequency doubling technology (FDT). This quicker glaucoma screening shows promise for future large-scale population studies.
Area of Science:
- Ophthalmology
- Medical Devices
- Diagnostic Accuracy
Background:
- Glaucoma detection relies on accurate visual field testing.
- Frequency doubling technology (FDT) is an established screening tool.
- Novel screening methods are needed to improve efficiency and accessibility.
Purpose of the Study:
- To compare the glaucoma detection accuracy of the "imo" screening program (ISP) with frequency doubling technology (FDT).
- To evaluate the testing time efficiency of ISP versus FDT.
Main Methods:
- A multicenter diagnostic accuracy study prospectively collected data from 76 non-glaucoma and 92 glaucomatous eyes.
- Patients underwent both ISP and FDT (C-20-1 screening program) on the same day.
- Diagnostic efficacy was assessed using receiver operating characteristic curves and areas under the curve (AUCs).
Main Results:
- ISP showed non-inferiority to FDT across all glaucoma stages (mild, moderate, advanced).
- AUC values for mild-stage glaucoma were 0.82 for ISP vs. 0.76 for FDT.
- ISP demonstrated significantly shorter testing times than FDT for all glaucoma stages (P < 0.001).
Conclusions:
- The ISP is a non-inferior and more time-efficient method for glaucoma detection compared to FDT.
- These findings support the use of ISP in large-scale population-based glaucoma screening programs.

